Xylem heads into its third-quarter report with a story that has improved on paper while the stock has gone the other way. Last quarter management raised its full-year profit and margin targets, pointed to surging data center demand and booked the largest orders in company history, yet the shares have fallen 15% since then while the S&P 500 gained more than 3%. That gap frames the question for this report: is the market looking past a slowing top line toward a deeper problem, or is it underpricing a company whose earnings engine is running better than its revenue suggests?
The Street is looking for earnings of $1.47 a share on revenue of $2.28 billion. That implies EPS growth of about 7% from $1.37 a year ago on revenue that is essentially flat, up roughly half a percent. In other words, this quarter is expected to be almost entirely a margin story. Management guided third-quarter EBITDA margin to 23.5% to 24%, a step up from the 23.3% posted in the second quarter, so hitting the upper half of that range would go a long way toward validating the case. The Earnings Whisper sits at $1.50, modestly above consensus, signaling that the more engaged crowd expects a small beat rather than a merely in-line print.
The full-year picture adds an intriguing wrinkle. Management lifted 2026 EPS guidance to $5.55 to $5.70, its first raise of the year, while trimming revenue to roughly $9.2 billion and narrowing organic growth to 2% to 3%. Consensus at $5.52 sits below the bottom of that range, suggesting analysts either have not fully bought the raise or are building in cushion for further revenue slippage. A reaffirmation of the EPS range, let alone a nudge toward the high end, would leave the Street meaningfully behind the company's own view.
The revenue debate centers on Measurement & Control Solutions. Electric metering projects were delayed as utilities grew cautious over affordability and upcoming elections, and segment orders rose just 2% last quarter with book-to-bill slipping below one, a sharp deceleration from double-digit order growth in prior quarters. If MCS orders stabilize or recover, the guidance cut looks like a timing issue. Another soft print would raise the uncomfortable possibility that the low-single-digit outlook for the segment is still too generous. China, where orders and sales have been running down roughly 30%, and the 80-20 walkaway program, which management said peaks at about a 2% revenue drag this year, help explain the flat top line but also need to stop getting worse.
On the other side of the ledger, Applied Water swung to 9% organic growth last quarter on data center strength, with data center orders up 300% and full-year data center revenue guided to triple. Sustaining that momentum is essential, because it is the clearest evidence that Xylem's mix is shifting toward faster-growing industrial customers. Backlog jumped to $5.3 billion on the Dow contract and an roughly $850 million 20-year outsourced water win, so investors should want to see that backlog holding up as it begins converting. Updates on the Waterfleet deal and the newly closed Trios acquisition will also show whether management's newer catalysts are gaining traction.
Sentiment has turned mildly bullish from slightly bearish heading into last quarter, yet the stock trades near $104, well below its 200-day moving average around $119 and not far above its post-earnings low of $98.58. That combination suggests expectations are cautious despite better chatter. The central issue is whether margin expansion and data center strength can keep outrunning the metering slowdown. If Xylem delivers on its margin guide and shows MCS orders finding a floor, the raised EPS outlook looks credible and the recent selloff looks overdone. If metering weakness spreads, the market's skepticism will have been well placed.